Gapping up
In reaction to earnings/guidance:
- TRMK +9.3%, FMBI +4.3%, SLGN +3.6%, COF +3.1% (also authorizes $7.5 bln stock repurchase program), ROL +2.5%, PFC +2.1% (also names new CEO), MSFT +1.6%, SBSI +1%, GLW +1%, CVLT +1%
Other news:
- AMC +155.6% (continues its short squeeze momentum)
- GME +66.9% (continues its short squeeze momentum)
- SRNE +5.4% (reports preliminary results of Phase 1b study of COVI-MSC for treatment of ICU COVID-19 patients)
- WBA +4.8% (confirms the appointment of Roz Brewer as the company's Chief Executive Officer; Stefano Pessina as Executive Chairman)
- GBT +4% (European Medicines Agency has completed the validation of GBT's Marketing Authorization Application for Oxbryta tablets and started its standard review process)
- CTMX +3.2% (Point72 Asset Mgmt discloses 9.1% stake)
- DPW +3% (Ault Global Holdings' Coolisys Technologies has received a purchase order for 5,000 ACECool 7kW residential EV charging systems for an aggregate of $1.75 mln and expects to receive orders for a substantially greater number of such chargers from iNetSupply)
- TLSA +1.3% (files shelf registration statement for to up to $250 mln in market value of its securities)
- REGN +1.1% (Regeneron Pharma and Columbia University researchers have independently confirmed findings that REGEN-COV antibody cocktail is active against SARS-CoV-2 variants; data included in bioRxiv paper and submitted for peer-reviewed publication)
Analyst comments:
- DKS +2.3% (upgraded to Buy from Neutral at Citigroup)
- DY +0.9% (upgraded to Overweight from Sector Weight at KeyBanc Capital Markets)